DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Brooks Laboratories Limited — Outcome of Board Meeting

NSE 5 hrs ago·13 Aug 2026, 2:33 pm

Company NSE

Brooks Laboratories Limited has announced the outcome of its board meeting, disclosing its financial results for the period ending June 30, 2026. This filing provides investors with a crucial update on the company's performance during this specific timeframe.

For investors, these results are a key indicator of the company's operational health and financial trajectory. They offer insight into the company's ability to generate revenue and manage its expenses, which are essential factors for assessing its future growth potential and stability.

Investors should closely examine the company's earnings, profit margins, and any commentary provided by management regarding future outlook. This information will help in evaluating whether the stock remains a suitable addition to a long-term investment portfolio.